Linking C-reactive protein to late-life disability in the National Health and Nutrition Examination Survey (NHANES) 1999-2002

Journals of Gerontology - Series A Biological Sciences and Medical Sciences

Volumn 61, Issue 4, 2006, Pages 380-387

  Kuo, Hsu Ko ^a   Bean, Jonathan F ^b   Yen, Chung Jen ^a   Leveille, Suzanne G ^c  

^a NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^b and Red Sox Foundation and Massachusetts General Hospital Home Base Program   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE PHASE PROTEIN; BIOCHEMICAL MARKER; C REACTIVE PROTEIN; INTERLEUKIN 6;

ADULT; AGED; CHRONIC DISEASE; CHRONIC INFLAMMATION; DAILY LIFE ACTIVITY; FEMALE; HEALTH SURVEY; HIGH RISK POPULATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL EXAMINATION; MUSCLE ISOMETRIC CONTRACTION; MUSCLE STRENGTH; NEPHELOMETRY; NUTRITION; PHYSICAL ACTIVITY; PHYSICAL DISABILITY; PRIORITY JOURNAL; REVIEW; RISK FACTOR; SELF REPORT; SOCIAL BEHAVIOR; WALKING;

EID: 33645990896     PISSN: 10795006     EISSN: None     Source Type: Journal    
DOI: 10.1093/gerona/61.4.380     Document Type: Review

References (39)

1. Ridker PM. Clinical application of C-reactive protein for cardiovascular disease detection and prevention. Circulation. 2003;107:363-369.
2. Gabay C, Kushner I. Acute-phase proteins and other systemic responses to inflammation. N Engl J Med. 1999;340:448-454.
3. Whitehead AS, Bruns GA, Markham AF, Colten HR, Woods DE. Isolation of human C-reactive protein complementary DNA and localization of the gene to chromosome 1. Science. 1983;221:69-71.
4. Kuta AE, Baum LL. C-reactive protein is produced by a small number of normal human peripheral blood lymphocytes. J Exp Med. 1986;164:321-326.
5. Cannon JG. Cytokines in aging and muscle homeostasis. J Gerontol A Biol Sci Med Sci. 1995;50A(Spec Iss):120-123.
6. Tisdale MJ. New cachexic factors. Curr Opin Clin Nutr Metab Care. 1998;1:253-256.
7. Janssen I, Heymsfield SB, Ross R. Low relative skeletal muscle mass (sarcopenia) in older persons is associated with functional impairment and physical disability. J Am Geriatr Soc. 2002;50:889-896.
8. Fisher AL. Of worms and women: sarcopenia and its role in disability and mortality. J Am Geriatr Soc. 2004;52:1185-1190.
9. Ferrucci L, Harris TB, Guralnik JM, et al. Serum IL-6 level and the development of disability in older persons. J Am Geriatr Soc. 1999;47:639-646.
10. Ferrucci L, Penninx BW, Volpato S, et al. Change in muscle strength explains accelerated decline of physical function in older women with high interleukin-6 serum levels. J Am Geriatr Soc. 2002;50:1947-1954.
11. Ravaglia G, Forti P, Maioli F, et al. Peripheral blood markers of inflammation and functional impairment in elderly community-dwellers. Exp Gerontol. 2004;39:1415-1422.
12. Bassey EJ, Fiatarone MA, O'Neill EF, Kelly M, Evans WJ, Lipsitz LA. Leg extensor power and functional performance in very old men and women. Clin Sci (Lond). 1992;82:321-327.
13. Skelton DA, Greig CA, Davies JM, Young A. Strength, power and related functional ability of healthy people aged 65-89 years. Age Ageing. 1994;23:371-377.
14. Bean JF, Kiely DK, Herman S, et al. The relationship between leg power and physical performance in mobility-limited older people. J Am Geriatr Soc. 2002;50:461-467.
15. Metter EJ, Conwit R, Tobin J, Fozard JL. Age-associated loss of power and strength in the upper extremities in women and men. J Gerontol Biol Sci. 1997;52A:B267-B276.
16. 1999-2000 National Health and Nutrition Examination Survey (NHANES). Available at http://www.cdc.gov/nchs/about/major/nhanes/ currentnhanes.htm. Bethesda, MD: National Center for Health Statistics.
17. 2001-2002 National Health and Nutrition Examination Survey (NHANES). Available at http://www.cdc.gov/nchs/about/major/ nhanes/current_nhanes_01_02. htm. Bethesda, MD: National Center for Health Statistics.
18. Suzuki T, Bean JF, Fielding RA. Muscle power of the ankle flexors predicts functional performance in community-dwelling older women. J Am Geriatr Soc. 2001;49:1161-1167.
19. Wilson G. Strength and power assessment. In: Bloomfield J, Ackland TR, Elliott BC, eds. Applied Anatomy and Biomechanics in Sport: Blackwell Publishing Inc.; 1994.
20. Guralnik JM, Ferrucci L, Pieper CF, et al. Lower extremity function and subsequent disability: consistency across studies, predictive models, and value of gait speed alone compared with the short physical performance battery. J Gerontol A Biol Sci Med Sci. 2000;55A:M221-M231.
21. National Heart, Lung, and Blood Institute. Obesity Education Initiative: The Evidence Report. Bethesda, MD: National Institutes of Health; 1998.
22. World Health Organization (WHO). Nutritional Anemia: Report of a WHO Scientific Group. Geneva, Switzerland: World Health Organization; 1968.
23. Pfeiffer CM, Huff DL, Smith SJ, Miller DT, Gunter EW. Comparison of plasma total homocysteine measurements in 14 laboratories: an international study. Clin Chem. 1999;45(8 Pt 1):1261-1268.
24. Nagi SZ. An epidemiology of disability among adults in the United States. Milbank Mem Fund Q Health Soc. 1976;54:439-467.
25. Cohen HJ, Pieper CF, Harris T, Rao KM, Currie MS. The association of plasma IL-6 levels with functional disability in community-dwelling elderly. J Gerontol Med Sci. 1997;52A:M201-M208.
26. Cesari M, Penninx BW, Pahor M, et al. Inflammatory markers and physical performance in older persons: the InCHIANTI study. J Gerontol A Biol Sci Med Sci. 2004;59A:242-248.
27. Visser M, Pahor M, Taaffe DR, et al. Relationship of interleukin-6 and tumor necrosis factor-alpha with muscle mass and muscle strength in elderly men and women: the Health ABC Study. J Gerontol Med Sci. 2002;57A:M326-M332.
28. Taaffe DR, Harris TB, Ferrucci L, Rowe J, Seeman TE. Cross-sectional and prospective relationships of interleukin-6 and C-reactive protein with physical performance in elderly persons: MacArthur studies of successful aging. J Gerontol Med Sci. 2000;55A:M709-M715.
29. Reuben DB, Judd-Hamilton L, Harris TB, Seeman TE. The associations between physical activity and inflammatory markers in high-functioning older persons: MacArthur Studies of Successful Aging. J Am Geriatr Soc. 2003;51:1125-1130.
30. Alexander RW. Inflammation and coronary artery disease. N Engl J Med. 1994;331:468-469.
31. Rajavashisth TB, Xu XP, Jovinge S, et al. Membrane type 1 matrix metalloproteinase expression in human atherosclerotic plaques: evidence for activation by proinflammatory mediators. Circulation. 1999;99:3103-3109.
32. Masdeu JC, Wolfson L, Lantos G, et al. Brain white-matter changes in the elderly prone to falling. Arch Neurol. 1989;46:1292-1296.
33. Brown M, Sinacore DR, Host HH. The relationship of strength to function in the older adult. J Gerontol A Biol Sci Med Sci. 1995;50A(Spec Iss):55-59.
34. Guralnik JM, Ferrucci L, Simonsick EM, Salive ME, Wallace RB. Lower-extremity function in persons over the age of 70 years as a predictor of subsequent disability. N Engl J Med. 1995;332:556-561.
35. Giampaoli S, Ferrucci L, Cecchi F, et al. Hand-grip strength predicts incident disability in non-disabled older men. Age Ageing. 1999;28:283-288.
36. Ostir GV, Markides KS, Black SA, Goodwin JS. Lower body functioning as a predictor of subsequent disability among older Mexican Americans. J Gerontol Med Sci. 1998;53:M491-M495.
37. Ridker PM, Rifai N, Pfeffer MA, Sacks F, Braunwald E. Long-term effects of pravastatin on plasma concentration of C-reactive protein. The Cholesterol and Recurrent Events (CARE) Investigators. Circulation. 1999;100:230-235.
38. Effect of nifedipine and cerivastatin on coronary endothelial function in patients with coronary artery disease: the ENCORE I Study (Evaluation of Nifedipine and Cerivastatin On Recovery of coronary Endothelial function). Circulation. 2003;107:422-428.
39. Vita JA, Yeung AC, Winniford M, et al. Effect of cholesterol-lowering therapy on coronary endothelial vasomotor function in patients with coronary artery disease. Circulation. 2000;102:846-851.